Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.

作者: Ritesh Gupta , Anoop Misra

DOI: 10.1016/J.DSX.2020.09.009

关键词:

摘要: Abstract Background Diabetes is recognized as an important comorbidity in patients with COVID-19 and a large amount of literature has become available regarding this. The aim this article to review the various aspects association between diabetes highlight clinically relevant points focus on India. Methods We searched Pubmed Google Scholar databases for articles published March 19, 2020 August 30, 2020. Results poor glycemic control are associated increased severity mortality COVID-19. Several clinical scenarios about hyperglycemia identified each these needs specific management strategies. Conclusion It prudent maintain good order minimize complications There need well conducted studies asses role individual antihyperglycemic therapies also behavior new onset diagnosed either after infection or during time.

参考文章(38)
Andrew P Hills, Ross Arena, Kamlesh Khunti, Chittaranjan Sakerlal Yajnik, Ranil Jayawardena, Christiani Jeyakumar Henry, Steven J Street, Mario J Soares, Anoop Misra, Epidemiology and determinants of type 2 diabetes in south Asia The Lancet Diabetes & Endocrinology. ,vol. 6, pp. 966- 978 ,(2018) , 10.1016/S2213-8587(18)30204-3
Anoop Misra, Hema Gopalan, Ranil Jayawardena, Andrew P. Hills, Mario Soares, Alfredo A. Reza‐Albarrán, Kaushik L. Ramaiya, Diabetes in developing countries Journal of Diabetes. ,vol. 11, pp. 522- 539 ,(2019) , 10.1111/1753-0407.12913
Ritesh Gupta, Amerta Ghosh, Awadhesh Kumar Singh, Anoop Misra, Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. ,vol. 14, pp. 211- 212 ,(2020) , 10.1016/J.DSX.2020.03.002
Amerta Ghosh, Ritesh Gupta, Anoop Misra, Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. ,vol. 14, pp. 273- 276 ,(2020) , 10.1016/J.DSX.2020.04.001
, Nancy Chow, Katherine Fleming-Dutra, Ryan Gierke, Aron Hall, Michelle Hughes, Tamara Pilishvili, Matthew Ritchey, Katherine Roguski, Tami Skoff, Emily Ussery, , Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 MMWR. Morbidity and Mortality Weekly Report. ,vol. 69, pp. 382- 386 ,(2020) , 10.15585/MMWR.MM6913E2
Awadhesh Kumar Singh, Ritesh Gupta, Amerta Ghosh, Anoop Misra, Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. ,vol. 14, pp. 303- 310 ,(2020) , 10.1016/J.DSX.2020.04.004
Ranil Jayawardena, Piumika Sooriyaarachchi, Michail Chourdakis, Chandima Jeewandara, Priyanga Ranasinghe, Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. ,vol. 14, pp. 367- 382 ,(2020) , 10.1016/J.DSX.2020.04.015
Amerta Ghosh, Koel Dutta, Kanika Tyagi, Ritesh Gupta, Anoop Misra, Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. ,vol. 14, pp. 577- 578 ,(2020) , 10.1016/J.DSX.2020.05.010
Lihua Zhu, Zhi-Gang She, Xu Cheng, Juan-Juan Qin, Xiao-Jing Zhang, Jingjing Cai, Fang Lei, Haitao Wang, Jing Xie, Wenxin Wang, Haomiao Li, Peng Zhang, Xiaohui Song, Xi Chen, Mei Xiang, Chaozheng Zhang, Liangjie Bai, Da Xiang, Ming-Ming Chen, Yanqiong Liu, Youqin Yan, Mingyu Liu, Weiming Mao, Jinjing Zou, Liming Liu, Guohua Chen, Pengcheng Luo, Bing Xiao, Changjiang Zhang, Zixiong Zhang, Zhigang Lu, Junhai Wang, Haofeng Lu, Xigang Xia, Daihong Wang, Xiaofeng Liao, Gang Peng, Ping Ye, Jun Yang, Yufeng Yuan, Xiaodong Huang, Jiao Guo, Bing-Hong Zhang, Hongliang Li, Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metabolism. ,vol. 31, ,(2020) , 10.1016/J.CMET.2020.04.021